{name}
{subtitle}
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~88 mi. (Bornova, Turkey, +192 more cities)
facility
Ege University Medicine of Faculty
biomarker
ER Positive, +1 more biomarker
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~88 mi. (Bornova, Turkey, +226 more cities)
facility
Ege University Medicine of Faculty ( Site 0661)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)
city
~88 mi. (Bornova, Turkey, +21 more cities)
facility
Ege University Medicine of Faculty ( Site 1105)
condition
Classical Hodgkin Lymphoma, +1 more condition
A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That Has Invaded the Muscle Wall of the Bladder and Who Cannot Get Cisplatin, a Type of Medicine Given to Treat Bladder Cancer.
city
~89 mi. (İzmir, Turkey, +137 more cities)
facility
Local Institution
drug
bempegaldesleukin, +2 more drugs
drug type
immunotherapy, +2 more types
Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)
city
~93 mi. (Balçova, Turkey, +16 more cities)
facility
Dokuz Eylül Üniversitesi ( Site 5002)
drug
BEACOPP regimen, +4 more drugs
drug type
chemotherapy, +1 more type